Healthcare Sales & Marketing Network News: Muscular Dystrophy

Searching News Database: Muscular Dystrophy

HSMN NewsFeed - 18 Oct 2024
CHMP Maintains Negative Opinion on Translarna(TM) Reexamination
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital

HSMN NewsFeed - 28 Feb 2023
Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2020
PTC Announces Translarna(TM) Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Jul 2020
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
Biopharmaceuticals Licensing

HSMN NewsFeed - 17 Apr 2020
PTC Therapeutics Announces New Leadership Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2020
Avidity Biosciences Appoints Joseph Baroldi as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2019
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 21 May 2019
Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Biopharmaceuticals Reimbursement Litigation

HSMN NewsFeed - 11 Dec 2018
GenEdit Closes $8.5 million Series Seed Financing
Regenerative Medicine Venture Capital Personnel

HSMN NewsFeed - 5 Sep 2018
ARMGO Pharma Receives FDA Orphan Drug Designation for ARM210/S48168 for the Treatment of Ryanodine Receptor Type 1 Related Myopathies
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Nov 2017
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Nov 2017
Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-Linked Myotubular Myopathy
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing

HSMN NewsFeed - 4 Oct 2017
Capricor Therapeutics Presents Positive Six-Month Results in Duchenne Muscular Dystrophy at World Muscle Society International Congress
Regenerative Medicine

HSMN NewsFeed - 8 Sep 2017
Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2017
Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jul 2017
Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients with Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 5 Jun 2017
PTC Therapeutics Announces Executive Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 May 2017
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 May 2017
Capricor Therapeutics Provides Update on ALLSTAR Trial
Regenerative Medicine Cardiology

HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2017
aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Feb 2017
Capricor Therapeutics Provides Update on Natriuretic Peptide Program
Biopharmaceuticals

HSMN NewsFeed - 10 Feb 2017
FDA Approves EMFLAZA(TM) (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Oct 2016
aTyr Pharma Receives FDA Fast Track Designation for Resolaris(TM) to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2016
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Aug 2016
Mallinckrodt Receives FDA Fast-Track Designation for Synacthen(R) Depot IND Application
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2016
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2016
PhaseBio Announces Leadership Team Appointments
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 11 Mar 2016
Bantam Pharmaceutical Appoints Dr. Michael Luther President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Feb 2016
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Nov 2015
Solid GT Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Oct 2015
Transgenomic Launches New Genetic Testing Service for Diagnosis of Charcot-Marie-Tooth Syndrome
Diagnostics Neurology Product Launch

HSMN NewsFeed - 2 Sep 2015
Summit Therapeutics Appoints Ralf Rosskamp, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2015
WAVE Life Sciences Raises $66 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jul 2015
aTyr Pharma Announces Transitions In Clinical Development & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2015
PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Feb 2015
Catabasis Names Rick Modi Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2014
PTC Therapeutics Announces Launch of Translarna(TM) (ataluren) in Germany
Biopharmaceuticals Product Launch

HSMN NewsFeed - 3 Jul 2014
Akashi Therapeutics Receives Fast Track Designation for HT-100 from FDA for the Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jul 2014
Akashi Therapeutics Receives Collective Funding of $1.5 Million to Support HT-100 Clinical Development
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 May 2014
Santhera Reports Positive Outcome for Catena(R)/Raxone(R) in Phase III DMD Trial Supported by Additional Respiratory Function Data
Biopharmaceuticals

HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 30 Dec 2013
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Devices FDA

HSMN NewsFeed - 12 Dec 2013
Retrophin Announces Agreement to Acquire Kyalin Biosciences
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 21 Nov 2013
Eloxx Pharmaceuticals, Ltd. Announced the Initial Closing of its First Round of Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Nov 2013
Jeffrey Paley, MD, Joins Retrophin Inc.’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2013
Cornelius E. Golding Joins Retrophin, Inc.’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2013
Retrophin Expands Management Team with Appointment of Steven R. Eby, R.Ph as Vice President, Global Strategy and Program Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2013
Retrophin Names Horacio Plotkin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2013
PTC Therapeutics Closes $60 Million Private Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2012
Sarepta Therapeutics' Lead Therapeutic Drugs for Ebola and Marburg Viruses Receive FDA Fast Track Designation
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jul 2012
AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2012
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 30 Jan 2012
Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera(R) Marketing Authorisation and Requests Further Information From the CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Dec 2011
AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Aug 2011
Medistem Submits Response to FDA Clinical Hold
Regenerative Medicine FDA

HSMN NewsFeed - 8 Jul 2011
Amsterdam Molecular Therapeutics Files Glybera(R) European Marketing Application for Re-examination
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Jun 2011
Repligen Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2011
AVI BioPharma Names Ed Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2011
AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Dec 2010
AVI BioPharma Provides Update on Duchenne Muscular Dystrophy Program
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2010
AVI BioPharma Names Chris Garabedian Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Dec 2010
Spinal Cord Injury Patient Treated With Non-Matched Adult Stem Cells
Regenerative Medicine Neurology

HSMN NewsFeed - 7 Dec 2010
Medistem Announces New Management Team
Regenerative Medicine Personnel

HSMN NewsFeed - 27 Oct 2010
AVI BioPharma Announces Key Leadership Appointments to Advance Capabilities in Drug Discovery, Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Sep 2010
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Apr 2010
AVI BioPharma Appoints David Boyle Interim President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Apr 2010
BioMarin Launches Firdapse in the European Union
Biopharmaceuticals

HSMN NewsFeed - 13 Apr 2010
Entest Biomedical Announces Intent to Acquire Medistem
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 25 Mar 2010
AVI BioPharma Announces Pending Changes to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2010
BioMarin to Acquire LEAD Therapeutics
Biopharmaceuticals Mergers & Acquisitions Oncology

HSMN NewsFeed - 19 Jan 2010
PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2009
AMT Announces Management Changes in Light of Refocused Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2009
AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 10 Sep 2009
StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
Regenerative Medicine Neurology

HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 19 Feb 2009
AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 12 Feb 2009
AVI BioPharma, Inc. Appoints Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2008
AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jul 2008
AVI BioPharma Appoints New Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2008
Santhera Receives First Product Approval: Health Canada Approves Catena(R) for Treatment of Friedreich's Ataxia
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 21 Jul 2008
Insmed Provides Update on IPLEX(TM) Programs
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Biopharmaceuticals Generics

HSMN NewsFeed - 13 Mar 2008
AVI BioPharma Announces Acquisition of Ercole Biotech
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Feb 2008
AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2007
AVI BioPharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Oralflo Helps the Medicine Go Down
Devices

HSMN NewsFeed - 28 Sep 2007
Santhera Announces Start of US Phase III Clinical Trial with SNT-MC17 in Friedreich's Ataxia and Provides Details on Study Design
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Sep 2007
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 2 Aug 2007
Stem Cell Therapy International Acquires Exclusive Worldwide Rights to New, Anti-Rejection Stem Cell Technology
Regenerative Medicine

HSMN NewsFeed - 17 Jul 2007
Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 9 Jul 2007
APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease Announces Completion of Patient Enrollment
Devices Drug Delivery Interventional Cardiology

HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2007
Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 7 Mar 2007
Insmed Announces Restructure, Settlement Ending IPLEX(TM) Patent Dispute
Biopharmaceuticals Litigation

HSMN NewsFeed - 6 Mar 2007
Litigation Settlement Reached Between Tercica, Genentech and Insmed
Biopharmaceuticals Litigation

HSMN NewsFeed - 20 Feb 2007
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 10 Jan 2007
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Biopharmaceuticals Neurology Licensing Distribution

HSMN NewsFeed - 29 Nov 2006
Stem Cell Therapy International Reports the Successful Treatment of a Stroke Patient With Their Proprietary Stem Cell Transplantation Therapy
Regenerative Medicine Neurology

HSMN NewsFeed - 3 Nov 2006
PTC Therapeutics Announces Positive Phase 2 Results For PTC124 in Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2006
Former Amgen Manufacturing Executive Joins Insmed
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2006
PTC Therapeutics Announces Encouraging Preliminary Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2006
FDA Awards PTC Therapeutics Orphan Products Development Grant for the Development of PTC124 in Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2006
Insmed Sues Tercica for False Advertising
Biopharmaceuticals Litigation

HSMN NewsFeed - 15 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Communication Device and Wheelchair Control for First Stroke Participant in Pilot Clinical Trial
Devices Neurology

HSMN NewsFeed - 14 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Computer Control for First ALS Patient in Pilot Clinical Trial
Devices Neurology

HSMN NewsFeed - 5 Oct 2006
Insmed Provides Update Concerning Virginia Unfair Competition Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 2 Oct 2006
Edison Pharma and Institute of Vision Enter Into Collaboration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 20 Jul 2006
Stem Cell Therapy International Names Lixian (John) Jiang, Chief Operating Officer, China Division
Regenerative Medicine Personnel

Return to NewsFeed

Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 46 additional stories matching:
Muscular Dystrophy
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!